Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema.

Ian PearceClare BaileyEmily FletcherFaruque D GhanchiChristina RennieCynthia SantiagoJackie NapierYit Yang

Published in: Eye (London, England) (2019)

Clinical experience reinforces that, when using aflibercept in DMO, the licensed posology or Protocol T regimens achieve the best outcomes.

Keyphrases